Ionna, the new charging network backed by automakers such as General Motors, Honda, Hyundai, and Toyota, entered a new phase today. The Tesla Supercharger network competitor is exiting public beta ...

The U.S. EV charging network Ionna is picking up speed in its infrastructure build-out as the nascent network aims to make good on its promise of installing tens of thousands of electric vehicle ...

OEM alliance and EV charging juggernaut IONNA has announced a key milestone today, transitioning from public beta testing in the US to a full-scale national release. The EV charging joint venture ...

After a rigorous testing phase in late 2024, automaker vehicle fleets and everyday drivers helped stress-test the IONNA network, completing more than 4,400 charging sessions, on over 80 unique ...

Look out, Tesla, there's a new fast-charging network in town. The Ionna network, a partnership between eight different automakers to build more fast chargers of their own, has just officially been ...

The Ionna EV charging network is a joint venture between GM, BMW, Honda, Hyundai, Kia, Mercedes-Benz, Stellantis, and Toyota. Following a pilot program, Ionna has transitioned from public beta to ...

There’s big news in the world of electric vehicle charging. On February 4, Ionna announced it’s shifting gears in a major way, transitioning “from a public beta to [a] full-scale national ...

Ionna, the new charging network backed by automakers such as General Motors, Honda, Hyundai, and Toyota, entered a new phase today. The Tesla Supercharger network competitor is exiting public beta ...

That haul helped Novo’s total sales for 2024 grow 26% at constant currencies to 290.4 billion kroner (nearly $41 billion), contributing to operating profits of 128.3 billion kroner ($18 billion ...

In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

The electric vehicle charging network is growing faster than ever across the United States. Now, Ionna—a new joint venture backed by major automakers including General Motors, Honda, Hyundai ...

Novo Nordisk (NVO) announced Friday that its popular obesity therapy, semaglutide, marketed as Wegovy, led to 20.7% weight loss over 72 weeks at a higher dose of 7.2 mg in a late-stage trial ...